ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic—a randomized controlled trial

ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic—a randomized controlled trial

Abstract Background Cardiovascular disease remains the primary cause of morbidity and mortality despite advancements in the treatment of patients with type 2 diabetes. Effective diabetes management extends beyond blood glucose control and includes cardiovascular prevention and treatment. However, th...

Full description

Bibliographic Details
Main Authors: Katrine Schultz Overgaard, Roda Abdulkadir Mohamed, Thomas Rueskov Andersen, Jess Lambrechtsen, Kenneth Egstrup, Søren Auscher
Format: Article
Language:English
Published: BMC 2024-07-01
Series:Cardiovascular Diabetology
Subjects:
Cardio-metabolic clinic
Type 2 diabetes
Cardiovascular disease
Heart disease
Vascular disease
Atherosclerosis
Online Access:https://doi.org/10.1186/s12933-024-02340-w

Internet

https://doi.org/10.1186/s12933-024-02340-w

Similar Items